港股异动丨信义光能(0968.HK)低开逾3% 拟折让8%配售2.82亿股 融资约26.62亿港元
格隆汇9月3日丨信义光能(0968.HK)低开逾3%,报9.95港元,总市值812.5亿港元。信义光能发布公告,2020年9月3日(联交所交易时段前),公司与Citigroup Global Market Limited立配售协议,据此,配售代理同意按悉数包销基准向不少于六名承配人配售2.82亿股配售股份,配售价为每股配售股份9.44港元,较配售协议日期前一日收市价10.26港元折让8%。此外,信义光能还遭执行董事陈曦在场内以每股均价9.9493港元减持约17.76万股,涉资约176.7万港元。减持后,陈曦最新持股数目为1,355,476股,持股比例为0.02%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.